Vall D'hebron Institute Of Oncology
Clinical trials sponsored by Vall D'hebron Institute Of Oncology, explained in plain language.
-
New drug cocktail aims to shrink kidney tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of three drugs (pembrolizumab, belzutifan, and lenvatinib) before surgery can shrink kidney tumors in people with localized clear cell renal cell carcinoma. About 150 participants will receive the drugs for 12 weeks before surgery, th…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Second chance: drug combo retested for tough colorectal cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether giving the drugs encorafenib and cetuximab again can help people with a specific type of advanced colorectal cancer (BRAF V600E-mutant) whose disease got worse after prior treatment with similar drugs. About 25 participants will receive the d…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC